573 related articles for article (PubMed ID: 22269678)
21. Glaucoma associated with Boston type I keratoprosthesis.
Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
[TBL] [Abstract][Full Text] [Related]
22. The Boston Keratoprosthesis in severe ocular trauma.
Harissi-Dagher M; Dohlman CH
Can J Ophthalmol; 2008 Apr; 43(2):165-9. PubMed ID: 18347618
[TBL] [Abstract][Full Text] [Related]
23. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety.
Verdejo-Gómez L; Peláez N; Gris O; Güell JL
Ophthalmic Surg Lasers Imaging; 2011; 42(6):446-52. PubMed ID: 21919432
[TBL] [Abstract][Full Text] [Related]
24. Corneal replacement using a synthetic hydrogel cornea, AlphaCor: device, preliminary outcomes and complications.
Hicks CR; Crawford GJ; Lou X; Tan DT; Snibson GR; Sutton G; Downie N; Werner L; Chirila TV; Constable IJ
Eye (Lond); 2003 Apr; 17(3):385-92. PubMed ID: 12724702
[TBL] [Abstract][Full Text] [Related]
25. Primary implantation of type I Boston keratoprosthesis in nonautoimmune corneal diseases.
Chang HY; Luo ZK; Chodosh J; Dohlman CH; Colby KA
Cornea; 2015 Mar; 34(3):264-70. PubMed ID: 25611395
[TBL] [Abstract][Full Text] [Related]
26. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis.
Aravena C; Yu F; Aldave AJ
Cornea; 2018 Jan; 37(1):3-10. PubMed ID: 28990994
[TBL] [Abstract][Full Text] [Related]
27. Boston keratoprosthesis for keratopathy in eyes with retained silicone oil: a new indication.
Iyer G; Srinivasan B; Gupta J; Rishi P; Sen PR; Bhende P; Gopal L; Padmanabhan P
Cornea; 2011 Oct; 30(10):1083-7. PubMed ID: 21705878
[TBL] [Abstract][Full Text] [Related]
28. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
[TBL] [Abstract][Full Text] [Related]
29. Results from the multicenter Boston Type 1 Keratoprosthesis Study.
Zerbe BL; Belin MW; Ciolino JB;
Ophthalmology; 2006 Oct; 113(10):1779.e1-7. PubMed ID: 16872678
[TBL] [Abstract][Full Text] [Related]
30. Donor Corneal Transplantation vs Boston Type 1 Keratoprosthesis in Patients with Previous Graft Failures: A Retrospective Single Center Study (An American Ophthalmological Society Thesis).
Akpek EK; Cassard SD; Dunlap K; Hahn S; Ramulu PY
Trans Am Ophthalmol Soc; 2015; 113():T3. PubMed ID: 26538773
[TBL] [Abstract][Full Text] [Related]
31. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the stability of Boston type I keratoprosthesis-donor cornea interface using anterior segment optical coherence tomography.
Garcia JP; Ritterband DC; Buxton DF; De la Cruz J
Cornea; 2010 Sep; 29(9):1031-5. PubMed ID: 20517152
[TBL] [Abstract][Full Text] [Related]
33. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation.
Ahmad S; Akpek EK; Gehlbach PL; Dunlap K; Ramulu PY
Am J Ophthalmol; 2015 Apr; 159(4):739-47. PubMed ID: 25555801
[TBL] [Abstract][Full Text] [Related]
34. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
Aravena C; Bozkurt TK; Yu F; Aldave AJ
Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
[TBL] [Abstract][Full Text] [Related]
35. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation.
Dunlap K; Chak G; Aquavella JV; Myrowitz E; Utine CA; Akpek E
Ophthalmology; 2010 Apr; 117(4):687-92. PubMed ID: 20096462
[TBL] [Abstract][Full Text] [Related]
36. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada.
Szigiato AA; Bostan C; Nayman T; Harissi-Dagher M
Br J Ophthalmol; 2020 Nov; 104(11):1601-1607. PubMed ID: 32066560
[TBL] [Abstract][Full Text] [Related]
37. Long-term complications associated with glaucoma drainage devices and Boston keratoprosthesis.
Li JY; Greiner MA; Brandt JD; Lim MC; Mannis MJ
Am J Ophthalmol; 2011 Aug; 152(2):209-18. PubMed ID: 21636070
[TBL] [Abstract][Full Text] [Related]
38. Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery.
Talajic JC; Agoumi Y; Gagné S; Moussally K; Harissi-Dagher M
Am J Ophthalmol; 2012 Feb; 153(2):267-274.e1. PubMed ID: 21982110
[TBL] [Abstract][Full Text] [Related]
39. Boston type 1 keratoprosthesis for primary congenital glaucoma.
Haugsdal JM; Goins KM; Greiner MA; Kwon YH; Alward WL; Wagoner MD
Br J Ophthalmol; 2016 Mar; 100(3):328-31. PubMed ID: 26206789
[TBL] [Abstract][Full Text] [Related]
40. [Long-term outcomes of Boston keratoprosthesis].
Mori Y; Nejima R; Minami K; Miyata K; Kamiya K; Fukud M
Nippon Ganka Gakkai Zasshi; 2013 Jan; 117(1):35-43. PubMed ID: 23424974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
